Background Local complications that require additional surgical proced
ures are an important problem for women with breast implants. Methods
We studied 749 women who lived in Olmsted County, Minnesota, and recei
ved a first breast implant at the Mayo Clinic between 1964 and 1991. W
e identified complications that occurred after the initial procedure a
nd after any subsequent implantation. A complication was defined as a
surgical procedure performed for any of the following reasons: capsula
r contracture; rupture of the implant; hematoma or bleeding; infection
or seroma of the wound; chronic pain; extrusion, leakage, or sweating
of the implant; necrosis of the nipple, areola, or flap; malfunction
of the filler port of a tissue expander; and wound dehiscence. Results
During follow-up (mean, 7.8 years; range, 0 to 25.8), 208 (27.8 perce
nt) of the women underwent 450 additional implant-related surgical pro
cedures. Ninety-one (20.2 percent) were anticipated, staged procedures
or were done because the patient requested a size change or aesthetic
improvement, and 359 procedures (79.8 percent) had at least one clini
cal indication (thus constituting a complication). Complications occur
red in 178 (23.8 percent) of the 749 women and involved 274 (18.8 perc
ent) of the 1454 breasts with implants and 321 (18.8 percent) of the 1
703 implants. The most frequent problem was capsular contraction (131
women), followed by implant rupture (43 [5.7 percent]), hematoma (43),
and wound infection (19). The rate of complications was significantly
lower (P<0.001) among women with cosmetic implants (6.5 percent at on
e year, 12 percent at five years) than among those who received implan
ts after mastectomy for breast cancer (21.8 percent at one year, 34 pe
rcent at five years) or prophylactic mastectomy (17.3 percent at one y
ear, 30.4 percent at five years). Conclusions Women who have had breas
t implantation frequently experience local complications during the su
bsequent five years. Complications were significantly less frequent am
ong patients who received implants for cosmetic reasons than among tho
se who received implants after mastectomy for cancer or for cancer pro
phylaxis. (C) 1997, Massachusetts Medical Society.